1.本数据库收录EMA集中程序以及经HMA协调通过互认可程序或分权程序获得批准上市的药品
2.查询欧盟成员国上市的相关信息，点击欧盟成员国上市
掌握医院、零售、 电商 三大终端市场的销售脉搏，就用 药品市场全终端分析系统 (←点击链接免费试用)
全面洞察药品零售数据，助力企业精准决策，把握市场增长，就用穿云众客-零售药品消费分析决策系统(←点击链接免费试用)
| 商标名 | 通用名称 | 中文名称 | ATC编码 | 授权日期 | 上市许可持有人 | 市场状态 |
|---|---|---|---|---|---|---|
| Hympavzi | marstacimab | 马塔西单抗 | B02BX11 | 2024-11-18 | Pfizer Europe MA EEIGxa0 | Authorised |
| Absimky | ustekinumab | 乌司奴单抗 | L04AC05 | 2024-12-12 | Accord Healthcare S.L.U. | Authorised |
| Alhemo | concizumab | 康赛珠单抗 | B02BX10 | 2024-12-13 | Novo Nordisk A/S | Authorised |
| Buprenorphine Neuraxpharm | buprenorphine | 盐酸丁丙诺啡 | N07BC01 | 2024-12-19 | Neuraxpharm Pharmaceuticals S.L. | Authorised |
| Fluad | influenza vaccine (surface antigen, inactivated, adjuvanted) | J07BB02 | 2024-11-15 | Seqirus Netherlands B.V. | Authorised | |
| Flucelvax | influenza vaccine (surface antigen, inactivated, prepared in cell cultures) | J07BB02 | 2024-11-15 | Seqirus Netherlands B.V. | Authorised | |
| Siiltibcy | Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10) | V04CF | 2025-01-13 | Serum Life Science Europe GmbH | Authorised | |
| Imuldosa | ustekinumab | 乌司奴单抗 | L04AC05 | 2024-12-12 | Accord Healthcare S.L.U. | Authorised |
| Epixram | levetiracetam | N03AX14 | Neuraxpharm Pharmaceuticals S.L. | Application withdrawn | ||
| Apremilast Viatris | apremilast | 阿普米司特 | L04AA32 | Viatris Limited | Application withdrawn | |
| Korjuny | catumaxomab | 卡妥索单抗 | L01FX03 | 2025-02-10 | Lindis Biotech GmbH | Authorised |
| Eltrombopag Viatris | eltrombopag | 艾曲泊帕乙醇胺 | B02BX05 | 2024-12-12 | Viatris Limited | Authorised |
| Wainzua | eplontersen | N07XX21 | 2025-03-06 | AstraZeneca ABxa0 | Authorised | |
| Hetronifly | serplulimab | 斯鲁利单抗 | L01FF12 | 2025-02-03 | Henlius Europe GmbH | Authorised |
| Pomalidomide Teva | pomalidomide | 泊马度胺 | L04AX06 | 2024-11-14 | Teva GmbH | Authorised |
| Opuviz | aflibercept | 阿柏西普 | S01LA05 | 2024-11-13 | Samsung Bioepis NL B.V. | Authorised |
| Afqlir | aflibercept | 阿柏西普 | S01LA05 | 2024-11-13 | Sandoz GmbH | Authorised |
| Penbraya | Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed) | J07AH11 | 2024-11-14 | Pfizer Europe MA EEIGxa0 | Withdrawn | |
| Theralugand | lutetium (177Lu) chloride | 氯化镥[177Lu] | V10X | 2024-11-22 | Eckert & Ziegler Radiopharma GmbH | Authorised |
| Elahere | mirvetuximab soravtansine | 索米妥昔单抗 | L01FX26 | 2024-11-14 | AbbVie Deutschland GmbH & Co. KG | Authorised |
